Travis Perkins shares knocked down by interest rates induced profit warning

Travis Perkins shares were the biggest FTSE 350 faller on Friday after the company said they were feeling the pressure of higher interest rates and inflation.

On Wednesday, the UK Investor Magazine included Travis Perkins in our premium article detailing FTSE 350 stocks most at risk of higher interest rates.

Today, these risks were confirmed as Travis Perkins said they were experiencing difficulties as a direct result of higher interest rates and issued a profit warning.

Travis Perkins said in a statement:

“Volumes in both the new build housing and private domestic RMI markets continue to be impacted by higher interest rates and weaker consumer confidence driven by persistent, higher than anticipated consumer price inflation.”

AJ Bell’s Russ Mould explains Travis Perkins’ challenges in their new home building and consumer-facing business.

“John Carter, when he was boss of Travis Perkins, used to say the health of the housing market was far less important to the business than repair, maintenance and improvement (RMI) demand for existing homeowners,” Russ Mould said.

“His argument was that you don’t need a sale or a purchase of a property to spend money with the builders’ merchant, and that RMI demand was less governed by the direction of interest rates.

“He also said new build homes were more of a sideshow for Travis Perkins than existing housing stock, calling work for the big housebuilders ‘padding’ and not that profitable.

“While Carter is no longer chief executive, it’s clear from Travis Perkins’ latest trading update that his argument would not stand up today.

“In its profit warning, the company cited weaker volumes in new build housing and private domestic RMI markets being affected by higher interest rates, together with weaker consumer confidence amid high levels of inflation.”

Buoyant FTSE 100 rises with global equities; Fraser Group’s spending spree continues

The FTSE 100 was heading into the weekend on a high after global equities rallied on hopes major economies were nearing the end of their hiking cycles.

Instalments by the Federal Reserve and ECB this week suggest that although there are more rate hikes to come, they are now largely priced into markets.

US and Asian stocks rallied overnight, and European stocks took hold of their tailcoats on Friday.

“A decent showing on Wall Street last night has helped to put investors in a good mood, with the key markets across Europe and Asia ending the trading week on a high,” said Russ Mould, investment director at AJ Bell.

The FTSE 100 was 0.2% higher at the time of writing on Friday.

FTSE 100 movers

Ocado continued a storming rally on Friday, gaining over 3% as the FTSE 100’s foremost performer. Ocado has gained 15% over the last five trading sessions.

Fraser Group was up 2.7% as the retailing group increased their stake in AO World to 21%. Fraser Group is on a spending spree, targeting online retailers AO World and ASOS. Fraser Group increased their ASOS stake to 10.6% yesterday.

Fraser Group took an initial 19% stake in AO World last week, saying the deal was the “culmination of productive talks over the last two years about establishing a strategic partnership”.

Miners were among the top fallers as investors booked profits after a strong rally in commodities companies ignited by Chinese stimulus. Antofagasta was down 1.6%, and Anglo-American dipped 2%.

The Future of e-Bikes and Making our Cities Greener with WATT Mobility

The UK Investor Magazine was thrilled to be joined by Frans Nomden, CEO of WATT Mobility for a deep dive into the future of e-bikes and how they are making our cities greener and cleaner.

Our cities are striving for cleaner forms of transportation and governments are promoting the use of bikes and e-bikes.

WATT Mobility is pursuing its growth strategy with a crowdfunding round on Seedrs. We discuss why WATT are crowdfunding now and the opportunity for investors.

Find out more about their crowdfunding round on Seedrs here.

McKinsey has produced a comprehensive report on the future of mobility, in which e-bikes play a leading role. Read the McKinsey report here.

WATT Mobility has carefully positioned itself as an affordable option for riders and is targeting deep penetration of the European market by increasing its reselling network to 800 stores from 180 currently.

Explore WATT Mobility’s e-bike range here.

AIM movers: Better outlook for CT Automotive and Marlowe considers disposal

0

Better news from automotive interior components supplier CT Automotive (LON: CTA) with its 2022 results. Last December, the company warned that the 2022 figures would be disappointing, and the loss was $14.5m. The new manufacturing plant in Mexico has opened. The order book and demand are strong, and the semiconductor shortages are easing. Pre-tax profit margin is currently 7.6%. The share price recovered 28.6% to 45p, although it has still halved so far this year.

Regulatory services provider Marlowe (LON: MRL) is believed to be considering the sale of its testing, inspection and certification division. It has been speculated that the division, which is Marlowe’s largest, could be worth £650m. That is similar to the market capitalisation of the company, which also has net debt of around £170m. The share price is 14.4% ahead at 677p.

Molecular diagnostics company genedrive (LON: GDR) is involved in a multi-partner grant award that will help to finance the validation and implementation of the Genedrive CYP2C19 ID kit pharmacogenetic test in emergency care. The overall programme is being led by the University of Manchester. The share price increased 8.7% to 18.75p.

Hutchmed (China) (LON: HCM) and its partner Takeda has published the results of the Phase III FRESCO-2 evaluating fruquintinib in patients with previously treated metastatic colorectal cancer in the Lancet. The treatment reduces the risk of death by one-third. The share price rose 3.99% to 215.25p.

Mirada (LON: MIRA) has fallen a further 48.3% to 1.55p ahead of the cancellation of the AIM quotation on Monday.

ValiRx (LON: VAL) has ended the evaluation of potential pancreatic and endometrial cancer drug. The profile was unsuitable for further development at this stage. The share price slumped 12.4% to 8.1p.

Red Rock Resources (LON: RRR) lost some of the gain after the announcement on Thursday that it had been granted an environmental certificate for a lithium project in Zimbabwe. The share price slipped 6% to 0.235p, but the share price is still 84.3% higher over the week.

Energy storage technology company Invinity Energy Systems (LON: IES) has reassured the market that its 2022 accounts will be published by the end of June and there is likely to be a reduction in provisions for contract losses. That means the overall loss will be lower. Revenues will be around £3.6m. There was cash of £15.4m at the end of May. The share price fell 5.68% to 41.5p.

Tower Resources (LON: TRP) says a study of its Namibian oil and gas exploration blocks shows evidence of a working petroleum system within the Dolphin Graben in PEL 96. An oil seep analysis is being undertaken, as well as a review of existing data on prospects. The share price dipped 5.38% to 0.044p.

ValiRx shares sink as cancer trials ceased

ValiRx shares were tanking on Friday after the life science announced they would discontinue research on a cancer treatment.

ValiRx was undertaking trials on a candidate for the treatment of endometrial, pancreatic and bile duct cancers in conjunction with Hokkaido University.

ValiRx said: “the profile of the product has been found to be unsuitable for further development at this stage and the evaluation will now cease.”

The trial was one of ValiRx’s main operational highlights in their recent half-year report and the outcome will be a blow to the company.

ValiRx shares were down 12% at the time of writing and now trade at the lowest levels since 2020.

Dr Suzy Dilly, CEO of ValiRx commented: 

“Although it’s disappointing not to be able to progress this project further, this highlights the importance of our process of evaluating academic projects prior to full in-licensing.  In addition to returning the data to Hokkaido, we have made recommendations for further work, and we will be following the scientific progress of project with interest.”

Tekcapital shares jump after portfolio company receives space grant

Tekcapital’s Guident has received a grant from Space Florida to develop remote monitoring and control for autonomous vehicles facilitated by low-orbit satellites.

Tekcapital’s shares jumped over 5% in early trade on Friday after the announcement.

The grant has been made as a part of the Florida-Israel Innovation Partnership program and will bring together Space Florida, Guident and their Israeli partner, NOVELSAT.

NOVELSAT and Guident are working to improve the connectivity and speed of Guident’s remote monitoring and control centres by utilising satellites.

The grant pays testament to Guident’s innovative approach and demonstrates the commercial opportunity in the future of autonomous vehicle safety.

“Through this extraordinary collaborative partnership, Space Florida is at the forefront of welding cutting-edge innovation with the boundless knowledge derived from scientific exploration. It thereby forges a path that shapes the very essence of the future of autonomous mobility,” stated Tony Gannon, Vice President of Research & Innovation for Space Florida.

Guident’s technology is focused on improving the safety of autonomous and has won major contracts, including one with the Jacksonville Transport Authority.

Space Florida’s grant will allow Guident to improve its offering and broaden the scope for commercial agreements.

“Guident is privileged to have the invaluable support and guidance of Space Florida with their unrivaled experience and strategic location for this new initiative,” stated Dr. Gabriel Castaneda, Guident’s Vice President for AI and Research.

“This funding will help propel us forward as we embark on the development and scale of an effective Remote Monitoring and Control Solution with enhanced vehicle safety, together with our Israeli Partner NOVELSAT.”

Why companies left AIM in May 2023

There were six companies that left AIM during May, including one that moved to the Main Market and another that was taken over. Golden Metal Resources (LON: GMET) was the only new admission.
15 May 2023
Ince Group
Legal services group Ince Group ran into financial difficulties. It was slow to fully integrate the acquisition of Ince, while cost cutting and rationalisation came too late. Last year, Ince Group raised £7m at 5p a share and took on an additional £1.6m loan following the acquisition of broker Arden Partners - for seven Ince shares for every 12 Arden shares. There was a cyber attack ...

JLEN Environmental increases NAV by 7%.

JLEN Environmental Assets Group Ltd (LON: JLEN) increased its NAV in the year to March 2023, helped by higher power prices and inflation.  

The Foresight managed investment trust riased NAV by 7% to 123.1p a share. The shut down of the Cramlington bioenergy plant held back the growth in the group valuation, but the time was used to implement improvements to the plant.

Cash flow from operations was £70.5m. JLEN is using £103.5m of its £200m bank facility. There are commitments to development assets and also scope for further acquisitions. It would be difficult to raise additional funds from a share issue in current market conditions.

Five acquisitions helped the portfolio valuation increase 13% to £898.5m. That means that there are 42 assets over seven sectors. Wind is the biggest sector accounting for 28% of gross assets and waste and bioenergy accounts for 26%.

Medium-term power prices are slightly higher. The fund manager has fixed a significant proportion of the prices of its power producing portfolio for up to two years.

The first battery storage investment is up and running. The West Gourdie 50MW lithium-ion plant started operations at the beginning of June and the 50%-owned Sandridge plant could be operational within 12 months. There are two other ready to build sites in the UK. The European market is less developed and has potential.

Three CNG refuelling stations are under construction. Overall, the assets under construction make up 10% of the portfolio.

There are plans to move into green hydrogen. The Foresight group already has interests in hydrogen and relevant infrastructure. JLEN has preferential rights to five projects under development in Germany. JLEN believes that the potential hydrogen operations could have higher returns than its other assets.  

There were total dividends of 7.14p a share last year – covered 1.5 times – and the plan is to increase them to 7.57p a share this year. At 114p, that provides a forecast yield of 6.6%.

FTSE 100 flat after hawkish Fed and ECB rate hike; Halma slides

The FTSE 100 was flat on Thursday as investors digested central bank guidance on interest rates after the Fed paused rate hikes and ECB hiked by 0.25%.

Last night the Federal Reserve held rates at 5%-5.25% but provided a hawkish outlook on rates which suggests the Fed will hike again twice this year. US stocks sank overnight and were pointing to a lower open on Thursday.

“The Fed’s decision to pause rates at the 5.0% to 5.25% range yesterday were met with a luke-warm reception, largely due to the hawkish tone set for the rest of the year,” said Derren Nathan, head of equity research, Hargreaves Lansdown.

The ECB followed on Thursday with a rate hike and a similarly hawkish outlook as ECB President Lagarde said it is likely the ECB will hike rates again in July.

The German DAX was down 0.6% at the time of writing while the FTSE 100 shook off rates concerns to gain 0.1%.

The Bank of England will meet and decide on interest rates next week – economists expect the BoE will also hike rates by 0.25%.

FTSE 100 movers

After avoiding demotion from the FTSE 100 by the skin of its teeth, Ocado shares have steadily rallied, and the rally continued on Thursday with a 3% gain.

Halma was the FTSE 100’s biggest disappointment on Thursday after the life-saving technology group provided lower guidance than the market had expected.

“Halma delivered record full-year record and profit, though headline figures were somewhat flattered by weaker sterling which meant its overseas income was worth more,” said Matt Britzman, equity analyst at Hargreaves Lansdown.

“Looking under the hood, revenue was above expectations, but there was some weakness in margins due to supply chain disruptions, particularly in the safety sector. Guidance here was a little lower than markets were expecting, with return on sales expected around 20% for the coming year – analysts had pencilled in 20.4%, which is likely why shares are down in early trading.”

Legal & General shares were down over 2% after CEO Nigel Wilson announced he would step down.

“The new boss at Legal & General has a hard act to follow. Since Nigel Wilson was appointed to the top job in June 2012, Legal & General shares have outperformed its life insurance peers, Aviva and Prudential, to chalk up a total return of more than 200%,” said AJ Bell investment director Russ Mould.

AIM movers: Eden Research flowers in Colombia and ex-dividends

0

Sustainable biopesticides developer Eden Research (LON: EDEN) has appointed a new product distributor in Colombia. Anasac Colombia will be exclusive distributor of Mevalone and it will seek regulatory approval for its use on freshly cut flowers to prevent Botrytis cinerea. Colombia exported $1.73bn worth of cut flowers in 2021. The share price is 25.4% higher at 8.4p and it has more than doubled in the past week.

Trading conditions at cosmetics supplier Warpaint London (LON: W7L) continue to improve with growth of 45% in the first five months of the year, which is higher than for the first quarter. In the five months to May 2023, net cash nearly doubled to £7.5m. Margins are improving and forecast 2023 pre-tax profit has been raised by one-fifth to £14.5m. Even though the shares have gone ex-dividend, the share price has jumped 11.9% to 282.5p, which is just under 20 times prospective earnings. Compound earnings growth for the next three years is expected to be around 19%.

Oriole Resources (LON: ORR) is using the latest drilling analysis for the 90%-owned Bibemi orogenic gold project in Cameroon to identify new targets. The early geophysical imagery indicates a much finer structural detail than previously visible. The share is 5.26% ahead at 0.2p.

Bezant Resources (LON: BZT) says a £700,000 loan facility is now repayable by the end of 2024 and the conversion price is fixed at 0.08p a share. The share price rose 6.67% to 0.04p.

Battery technology developer AMTE Power (LON: AMTE) says it needs to complete a financing within four weeks. There is no certainty that any money will be raised and that means that shareholders may end up with nothing. The share price has slumped 70.6% to 15p.

Crystal Amber Holdings (LON: CRS) shares have gone ex-dividend and fallen 28% to 63p.

Chaarat Gold Holdings (LON: CGH) finished 2022 with net debt of $51m. Cash was $600,000 and that fell to $500,000, after drawing down $2m of a working capital facility. Cash generated from the Kapan mine are not enough to cover expenses and capital investment. The previously announced $250m investment by Xiwang International has still to go ahead. The share price slipped 21.2% to 9.1p.

Aptamer (LON: APTA) has lost some of yesterday’s gains on the back of a successful development of a lateral flow test to diagnose early Alzheimer’s disease. The share price has fallen back 17.1% to 14.5p., which is still 61% ahead of one week ago.

Graphene technology developer Versarien (LON: VRS) is holding a general meeting to gain shareholder approval to raise money through share issues without having to involve the existing investors. Non-core assets are being sold but cash may be required before that happens. The share price has been on the rise since the results on Friday but declined 19.7% to 2.655p on the news.

GB Group (LON: GBG) reported a loss for the year to March 2023. That was mainly due to a non-cash goodwill impairment charge. Excluding one-offs, the identity services provider was still profitable, but it was hit by weak demand from cryptocurrency and fintech customers. The total dividend was raised by 5% to 4p a share. The share price has fallen 12.6% to 250.6p.

Ex-dividends

Facilities by ADF (LON: ADF) is paying a final dividend of 0.9p a share and the share price is down 0.5p to 58.5p.

Animalcare (LON: ANCR) is paying a final dividend of 2.4p a share and the share price is unchanged at 181.5p.

Camellia (LON: CAM) is paying a final dividend of 102p a share and the share price is 100p lower at 6025p.

Crystal Amber Fund (LON: CRS) is paying a dividend of 25p a share and the share price fell 24.5p to 63p.

EMIS (LON: EMIS) is paying a final dividend of 21.1p a share and the share price is 21p lower at 1329p.

Inspired (LON: INSE) is paying a final dividend of 0.01p a share and the share price fell 0.05p to 10.7p.

Impax Asset Management (LON: IPX) is paying an interim dividend of 4.7p a share and the share price is 13.5p lower at 611.5p.

Keystone Law Group (LON: KEYS) is paying a dividend of 10.9p a share and the share price declined 6.5p to 437.5p.

Manx Financial Group (LON: MFX) is paying a final dividend of 0.38p a share and the share price is unchanged at 22p.

Rotala (LON: ROL) is paying a final dividend of 1p a share and the share price is 1p lower at 44.5p.

Warpaint London (LON: W7L) is paying a final dividend of 4.5p a share and the share price jumped 30p to 282.5p.